The pace of postpaid phone customer defections, or churn, hit 0.97%, up from 0.85% a year ago. The firm increased its ...

Design software company Figma has set its tentative IPO pricing at $25-$28 per share, per a regulatory filing. This would ...

The latest batch of robust earnings results from major companies helped lift stocks, with the S&P 500 and Nasdaq Composite reaching new highs. The U.S. economy is set to slow, leading economic ...

Cleveland-Cliffs reports a per-share loss of 50 cents from sales of $4.9 billion. Wall Street was looking a per-share loss of 71 cents from sales of $4.9 billion. Verizon's Postpaid Phone Losses ...

-- For many of these favored stocks, the share prices are close to the consensus price targets, or even exceed them. Most analysts set 12-month price targets. So we made one more cut to 15 stocks for ...

While AGF Management's struggles are far from over, we believe the firm is on the right track. Long bouts of investment underperformance and increased competition have weakened the firm's competitive ...

Booth is also the central figure in a recent documentary, "Tune Out the Noise," directed by Oscar winner Errol Morris. The film explores how academic research at the University of Chicago transformed ...

My husband recently received a $50,000 inheritance. We have no idea what to do with it. We want to be wise, but everything is so confusing. I have early Alzheimer's and have trouble organizing my ...

Don't miss: 'We are acquaintances, not friends': My neighbors need somewhere to stay after a house fire. Do I say yes? You're very welcome in advance (YVWIA).

Cleveland-Cliffs reports a per-share loss of 50 cents from sales of $4.9 billion. Wall Street was looking a per-share loss of 71 cents from sales of $4.9 billion. The Ether Machine plans to manage ...

Intel's stock rose 0.7% on Monday. Shares are up almost 9% since the company's last earnings report, but the S&P 500 SPX is up nearly 15% in that span and the PHLX Semiconductor Index SOX is up almost ...

Commerce Secretary Howard Lutnick said Trump's new tariff policies are focused on ending the U.S.'s reliance on foreign supply of key pharmaceutical products. "We are proud that AstraZeneca has made ...